U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07013058) titled 'Evaluation of a Nigella Sativa Extract (10% Thymoquinone, Nisatol(R)) in Perimenopausal Women With Metabolic Syndrome' on May 29.
Brief Summary: A prospective, multicenter, randomized controlled study evaluating the efficacy and safety of a Nigella sativa extract standardized to 10% thymoquinone (Nisatol(R)) in perimenopausal women with metabolic syndrome. The study will assess changes in metabolic and blood pressure parameters, as well as improvements in menopausal symptoms and quality of life.
Study Start Date: June 15
Study Type: INTERVENTIONAL
Condition:
Metabolic Syndrome
Elevated Blood Pressure
Intervention:
DIETARY_SUPP...